These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9356335)

  • 21. Basic amino acid residues at the carboxy-terminal eleven amino acid region of the phosphoprotein (P) are required for transcription but not for replication of vesicular stomatitis virus genome RNA.
    Das T; Pattnaik AK; Takacs AM; Li T; Hwang LN; Banerjee AK
    Virology; 1997 Nov; 238(1):103-14. PubMed ID: 9375014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-1 tat transcriptional activity is regulated by acetylation.
    Kiernan RE; Vanhulle C; Schiltz L; Adam E; Xiao H; Maudoux F; Calomme C; Burny A; Nakatani Y; Jeang KT; Benkirane M; Van Lint C
    EMBO J; 1999 Nov; 18(21):6106-18. PubMed ID: 10545121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tat and rev differentially affect restricted replication of human immunodeficiency virus type 1 in various cells.
    Duan L; Oakes JW; Ferraro A; Bagasra O; Pomerantz RJ
    Virology; 1994 Mar; 199(2):474-8. PubMed ID: 8122376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication.
    Accolla RS; Mazza S; De Lerma Barbaro A; De Maria A; Tosi G
    Eur J Immunol; 2002 Oct; 32(10):2783-91. PubMed ID: 12355430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
    Nevado J; Tenbaum SP; Castillo AI; Sánchez-Pacheco A; Aranda A
    J Mol Endocrinol; 2007 Jun; 38(6):587-601. PubMed ID: 17556530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA immunization with HIV-1 tat mutated in the trans activation domain induces humoral and cellular immune responses against wild-type Tat.
    Caselli E; Betti M; Grossi MP; Balboni PG; Rossi C; Boarini C; Cafaro A; Barbanti-Brodano G; Ensoli B; Caputo A
    J Immunol; 1999 May; 162(9):5631-8. PubMed ID: 10228047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutting edge: a short polypeptide domain of HIV-1-Tat protein mediates pathogenesis.
    Boykins RA; Mahieux R; Shankavaram UT; Gho YS; Lee SF; Hewlett IK; Wahl LM; Kleinman HK; Brady JN; Yamada KM; Dhawan S
    J Immunol; 1999 Jul; 163(1):15-20. PubMed ID: 10384093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of Tat in HIV-1 replication: an activator and/or a suppressor?
    Liang C; Wainberg MA
    AIDS Rev; 2002; 4(1):41-9. PubMed ID: 11998784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions between Tat and TAR and human immunodeficiency virus replication are facilitated by human cyclin T1 but not cyclins T2a or T2b.
    Wimmer J; Fujinaga K; Taube R; Cujec TP; Zhu Y; Peng J; Price DH; Peterlin BM
    Virology; 1999 Mar; 255(1):182-9. PubMed ID: 10049833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones.
    Deng L; de la Fuente C; Fu P; Wang L; Donnelly R; Wade JD; Lambert P; Li H; Lee CG; Kashanchi F
    Virology; 2000 Nov; 277(2):278-95. PubMed ID: 11080476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional cross-talk of HIV-1 Tat with p53 through its C-terminal domain.
    Ariumi Y; Kaida A; Hatanaka M; Shimotohno K
    Biochem Biophys Res Commun; 2001 Sep; 287(2):556-61. PubMed ID: 11554765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-I TAT inhibits PKR activity by both RNA-dependent and RNA-independent mechanisms.
    Cai R; Carpick B; Chun RF; Jeang KT; Williams BR
    Arch Biochem Biophys; 2000 Jan; 373(2):361-7. PubMed ID: 10620360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication.
    Fitzon T; Leschonsky B; Bieler K; Paulus C; Schröder J; Wolf H; Wagner R
    Virology; 2000 Mar; 268(2):294-307. PubMed ID: 10704338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator.
    Marcello A; Zoppé M; Giacca M
    IUBMB Life; 2001 Mar; 51(3):175-81. PubMed ID: 11547919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human immunodeficiency virus type 2 (HIV-2) trans-activator (Tat): functional domains and the search for trans-dominant negative mutants.
    Arya SK
    AIDS Res Hum Retroviruses; 1993 Sep; 9(9):839-48. PubMed ID: 8257633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TAR- and Tat-independent replication of human immunodeficiency virus type 1 in human hepatoma cells.
    Zhu M; Duan L; Pomerantz RJ
    AIDS Res Hum Retroviruses; 1996 Aug; 12(12):1093-101. PubMed ID: 8844014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conservative mutations in the putative metal-binding region of human immunodeficiency virus tat disrupt virus replication.
    Sadaie MR; Mukhopadhyaya R; Benaissa ZN; Pavlakis GN; Wong-Staal F
    AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1257-63. PubMed ID: 2078407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal Tat-mediated activation of the HIV-1 LTR promoter requires a full-length TAR RNA hairpin.
    Verhoef K; Tijms M; Berkhout B
    Nucleic Acids Res; 1997 Feb; 25(3):496-502. PubMed ID: 9016587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of HIV-1 replication and reactivation from latency by tat transdominant negative mutants in the cysteine rich region.
    Caputo A; Grossi MP; Bozzini R; Rossi C; Betti M; Marconi PC; Barbanti-Brodano G; Balboni PG
    Gene Ther; 1996 Mar; 3(3):235-45. PubMed ID: 8646555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of human immunodeficiency virus type 1 promoter/TAR regions and tat1 genes derived from individuals with different rates of disease progression.
    Kirchhoff F; Greenough TC; Hamacher M; Sullivan JL; Desrosiers RC
    Virology; 1997 Jun; 232(2):319-31. PubMed ID: 9191845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.